Affinimark Technologies

About:

Affinimark Technologies is a bioscience company developing medical diagnostic products for unmet medical needs.

Website: http://www.affinimark.com

Top Investors: Connecticut Innovations, LaunchCapital

Description:

Affinimark Technologies, a private bioscience company based in New Haven, Connecticut, develops proprietary medical diagnostic products addressing market opportunities and serious unmet medical/surgical needs. Its lead product, CerebrostripTM, is a strip-based diagnostic test, derived from Affinimark's own cutting edge research, that will quickly and cost-effectively provide a definitive determination whether a patient has suffered a cerebrospinal fluid leak as a result of surgery or trauma. No such product is currently available, resulting in significant risk to the patient and cost to the healthcare system.

Total Funding Amount:

$2.91M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New Haven, Connecticut, United States

Founded Date:

2007-01-01

Founders:

Harry H. Penner

Number of Employees:

1-10

Last Funding Date:

2016-03-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai